Microba Life Sciences Stock EBITDA
| MAP Stock | 0.19 0.01 5.56% |
Microba Life Sciences fundamentals help investors to digest information that contributes to Microba Life's financial success or failures. It also enables traders to predict the movement of Microba Stock. The fundamental analysis module provides a way to measure Microba Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Microba Life stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -17.1 M | -16.2 M |
Microba | EBITDA |
Microba Life Sciences Company EBITDA Analysis
Microba Life's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Microba Life EBITDA | (17.1 M) |
Most of Microba Life's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microba Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Microba Ebitda
Ebitda |
|
According to the company disclosure, Microba Life Sciences reported earnings before interest,tax, depreciation and amortization of (17.1 Million). This is much lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The ebitda for all Australia stocks is notably higher than that of the company.
Microba EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microba Life's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microba Life could also be used in its relative valuation, which is a method of valuing Microba Life by comparing valuation metrics of similar companies.Microba Life is currently under evaluation in ebitda category among its peers.
Microba Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (1.65) % | ||||
| Operating Margin | (1.31) % | ||||
| Current Valuation | 61.31 M | ||||
| Shares Outstanding | 447.85 M | ||||
| Shares Owned By Insiders | 54.55 % | ||||
| Shares Owned By Institutions | 22.83 % | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 6.67 X | ||||
| Revenue | 12.09 M | ||||
| Gross Profit | 2.68 M | ||||
| EBITDA | (17.1 M) | ||||
| Net Income | (19.94 M) | ||||
| Cash And Equivalents | 12.43 M | ||||
| Total Debt | 1.58 M | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (15.57 M) | ||||
| Earnings Per Share | (0.05) X | ||||
| Target Price | 0.34 | ||||
| Beta | 2.7 | ||||
| Market Capitalization | 80.61 M | ||||
| Total Asset | 58.04 M | ||||
| Retained Earnings | (63.82 M) | ||||
| Working Capital | 33.7 M | ||||
| Net Asset | 58.04 M |
About Microba Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microba Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microba Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microba Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microba Stock Analysis
When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.